Grochow LB - Search Results

1

A phase II trial of topotecan in patients with previously untreated pancreatic cancer.

O'Reilly S, Donehower RC, Rowinsky EK, Ord S, Grochow LB. O'Reilly S, et al. Among authors: grochow lb. Anticancer Drugs. 1996 Jun;7(4):410-4. doi: 10.1097/00001813-199606000-00006. Anticancer Drugs. 1996. PMID: 8826609 Clinical Trial.

2

Phase I trial of taxol in patients with advanced cancer.

Donehower RC, Rowinsky EK, Grochow LB, Longnecker SM, Ettinger DS. Donehower RC, et al. Among authors: grochow lb. Cancer Treat Rep. 1987 Dec;71(12):1171-7. Cancer Treat Rep. 1987. PMID: 2891441

3

Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Dole GB, Rowinsky EK, Ettinger DS, Graham ML, McGuire WP, Donehower RC. Grochow LB, et al. J Natl Cancer Inst. 1989 Jan 18;81(2):124-30. doi: 10.1093/jnci/81.2.124. J Natl Cancer Inst. 1989. PMID: 2909752

4

Clinical and pharmacologic reappraisal of dichloromethotrexate.

Hantel A, Rowinsky EK, Noe DA, McGuire WP, Grochow LB, Vito BL, Ettinger DS, Donehower RC. Hantel A, et al. Among authors: grochow lb. J Natl Cancer Inst. 1988 Dec 7;80(19):1547-53. doi: 10.1093/jnci/80.19.1547. J Natl Cancer Inst. 1988. PMID: 3193470

5

Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity.

Rowinsky EK, Noe DA, Orr DW, Grochow LB, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. J Natl Cancer Inst. 1988 Jul 6;80(9):671-8. doi: 10.1093/jnci/80.9.671. J Natl Cancer Inst. 1988. PMID: 3373556

6

Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.

Rowinsky EK, Ettinger DS, McGuire WP, Noe DA, Grochow LB, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. Cancer Res. 1987 Nov 1;47(21):5788-95. Cancer Res. 1987. PMID: 3664482

7

Camptothecin analogues: studies from the Johns Hopkins Oncology Center.

Slichenmyer WJ, Rowinsky EK, Grochow LB, Kaufmann SH, Donehower RC. Slichenmyer WJ, et al. Among authors: grochow lb. Cancer Chemother Pharmacol. 1994;34 Suppl:S53-7. doi: 10.1007/BF00684864. Cancer Chemother Pharmacol. 1994. PMID: 7520844 Clinical Trial.

8

Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

Rowinsky EK, Noe DA, Grochow LB, Sartorious SE, Bowling MK, Chen TL, Lubejko BG, Kaufmann SH, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. J Clin Oncol. 1995 Aug;13(8):1975-84. doi: 10.1200/JCO.1995.13.8.1975. J Clin Oncol. 1995. PMID: 7636538 Clinical Trial.

9

Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.

Rowinsky EK, Adjei A, Donehower RC, Gore SD, Jones RJ, Burke PJ, Cheng YC, Grochow LB, Kaufmann SH. Rowinsky EK, et al. Among authors: grochow lb. J Clin Oncol. 1994 Oct;12(10):2193-203. doi: 10.1200/JCO.1994.12.10.2193. J Clin Oncol. 1994. PMID: 7931489 Clinical Trial.

10

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

Rowinsky EK, Grochow LB, Ettinger DS, Sartorius SE, Lubejko BG, Chen TL, Rock MK, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. Cancer Res. 1994 Jan 15;54(2):427-36. Cancer Res. 1994. PMID: 8275479 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters